Avonex (interferon beta-1a), the new treatment for multiple sclerosis (MS)
June 1996
There's a lot of excitement about Avonex (interferon beta-1a), the new treatment for multiple sclerosis (MS).
Avonex is a beta-interferon...but it's chemically different from the other MS treatment, Betaseron (interferon beta-1b). That might explain some of the differences in their effects.
Both Avonex and Betaseron reduce the frequency of attacks in patients with the relapsing forms of MS.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote